Diabetes-associated sustained activation of the transcription factor nuclear factor-kappaB - PubMed (original) (raw)
. 2001 Dec;50(12):2792-808.
doi: 10.2337/diabetes.50.12.2792.
S Schiekofer, M Schwaninger, M Andrassy, P M Humpert, J Chen, M Hong, T Luther, T Henle, I Klöting, M Morcos, M Hofmann, H Tritschler, B Weigle, M Kasper, M Smith, G Perry, A M Schmidt, D M Stern, H U Häring, E Schleicher, P P Nawroth
Affiliations
- PMID: 11723063
- DOI: 10.2337/diabetes.50.12.2792
Diabetes-associated sustained activation of the transcription factor nuclear factor-kappaB
A Bierhaus et al. Diabetes. 2001 Dec.
Abstract
Activation of the transcription factor nuclear factor-kappaB (NF-kappaB) has been suggested to participate in chronic disorders, such as diabetes and its complications. In contrast to the short and transient activation of NF-kappaB in vitro, we observed a long-lasting sustained activation of NF-kappaB in the absence of decreased IkappaBalpha in mononuclear cells from patients with type 1 diabetes. This was associated with increased transcription of NF-kappaBp65. A comparable increase in NF-kappaBp65 antigen and mRNA was also observed in vascular endothelial cells of diabetic rats. As a mechanism, we propose that binding of ligands such as advanced glycosylation end products (AGEs), members of the S100 family, or amyloid-beta peptide (Abeta) to the transmembrane receptor for AGE (RAGE) results in protein synthesis-dependent sustained activation of NF-kappaB both in vitro and in vivo. Infusion of AGE-albumin into mice bearing a beta-globin reporter transgene under control of NF-kappaB also resulted in prolonged expression of the reporter transgene. In vitro studies showed that RAGE-expressing cells induced sustained translocation of NF-kappaB (p50/p65) from the cytoplasm into the nucleus for >1 week. Sustained NF-kappaB activation by ligands of RAGE was mediated by initial degradation of IkappaB proteins followed by new synthesis of NF-kappaBp65 mRNA and protein in the presence of newly synthesized IkappaBalpha and IkappaBbeta. These data demonstrate that ligands of RAGE can induce sustained activation of NF-kappaB as a result of increased levels of de novo synthesized NF-kappaBp65 overriding endogenous negative feedback mechanisms and thus might contribute to the persistent NF-kappaB activation observed in hyperglycemia and possibly other chronic diseases.
Similar articles
- Activation of tubular epithelial cells in diabetic nephropathy.
Morcos M, Sayed AA, Bierhaus A, Yard B, Waldherr R, Merz W, Kloeting I, Schleicher E, Mentz S, Abd el Baki RF, Tritschler H, Kasper M, Schwenger V, Hamann A, Dugi KA, Schmidt AM, Stern D, Ziegler R, Haering HU, Andrassy M, van der Woude F, Nawroth PP. Morcos M, et al. Diabetes. 2002 Dec;51(12):3532-44. doi: 10.2337/diabetes.51.12.3532. Diabetes. 2002. PMID: 12453911 - Advanced glycation end product (AGE)-mediated induction of tissue factor in cultured endothelial cells is dependent on RAGE.
Bierhaus A, Illmer T, Kasper M, Luther T, Quehenberger P, Tritschler H, Wahl P, Ziegler R, Müller M, Nawroth PP. Bierhaus A, et al. Circulation. 1997 Oct 7;96(7):2262-71. doi: 10.1161/01.cir.96.7.2262. Circulation. 1997. PMID: 9337199 - Activation of receptor for advanced glycation end products: a mechanism for chronic vascular dysfunction in diabetic vasculopathy and atherosclerosis.
Schmidt AM, Yan SD, Wautier JL, Stern D. Schmidt AM, et al. Circ Res. 1999 Mar 19;84(5):489-97. doi: 10.1161/01.res.84.5.489. Circ Res. 1999. PMID: 10082470 Review. - Preventing activation of receptor for advanced glycation endproducts in Alzheimer's disease.
Lue LF, Yan SD, Stern DM, Walker DG. Lue LF, et al. Curr Drug Targets CNS Neurol Disord. 2005 Jun;4(3):249-66. doi: 10.2174/1568007054038210. Curr Drug Targets CNS Neurol Disord. 2005. PMID: 15975028 Review.
Cited by
- The Receptor for Advanced Glycation End Products (RAGE) Is Associated with Persistent Atrial Fibrillation.
Lancefield TF, Patel SK, Freeman M, Velkoska E, Wai B, Srivastava PM, Horrigan M, Farouque O, Burrell LM. Lancefield TF, et al. PLoS One. 2016 Sep 14;11(9):e0161715. doi: 10.1371/journal.pone.0161715. eCollection 2016. PLoS One. 2016. PMID: 27627677 Free PMC article. - Angelika Bierhaus, 1962-2012.
Nawroth PP. Nawroth PP. Diabetologia. 2012 Jul;55(7):1863-4. doi: 10.1007/s00125-012-2574-5. Diabetologia. 2012. PMID: 22580992 No abstract available. - Protein malnutrition potentiates the amplifying pathway of insulin secretion in adult obese mice.
Leite NC, de Paula F, Borck PC, Vettorazzi JF, Branco RC, Lubaczeuski C, Boschero AC, Zoppi CC, Carneiro EM. Leite NC, et al. Sci Rep. 2016 Sep 16;6:33464. doi: 10.1038/srep33464. Sci Rep. 2016. PMID: 27633083 Free PMC article. - The mechanisms of glycolipid metabolism disorder on vascular injury in type 2 diabetes.
Chen X, Shi C, Wang Y, Yu H, Zhang Y, Zhang J, Li P, Gao J. Chen X, et al. Front Physiol. 2022 Aug 31;13:952445. doi: 10.3389/fphys.2022.952445. eCollection 2022. Front Physiol. 2022. PMID: 36117707 Free PMC article. Review. - S100B is increased in Parkinson's disease and ablation protects against MPTP-induced toxicity through the RAGE and TNF-α pathway.
Sathe K, Maetzler W, Lang JD, Mounsey RB, Fleckenstein C, Martin HL, Schulte C, Mustafa S, Synofzik M, Vukovic Z, Itohara S, Berg D, Teismann P. Sathe K, et al. Brain. 2012 Nov;135(Pt 11):3336-47. doi: 10.1093/brain/aws250. Brain. 2012. PMID: 23169921 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials